Pradaxa patients

Protection for a wide range of atrial fibrillation (AF) patients1

PRADAXA is indicated for the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF) and one or more risk factors, such as:1

  • Prior stroke, transient ischemic attack (TIA)
  • Heart failure, (NYHA Class ≥ 2)
  • Age ≥ 75 years
  • Diabetes mellitus
  • Hypertension

This section is designed to answer your questions about PRADAXA patient types. Please click on the appropriate link within each section for the information you need.

PETER DEMANDS THE BEST FROM HIS TREATMENT

 

Active lifestyle, travels with work

Clinical characteristics

  • Age: 65, with atrial fibrillation
  • Current medications: ACE inhibitor
  • Co-morbidities: Hypertension, prior TIA
  • CHA2DS2- VASc score: 3 
  • Creatinine clearance: 79.1 mL/min

ELLEN WANTS PEACE OF MIND

 

Enjoying retirement, spending time with her grandchildren

Clinical characteristics

  • Age: 76, with atrial fibrillation
  • Current medications: Oral antidiabetic agent, ACE inhibitor, diuretic
  • Co-morbidities: Diabetes, hypertension
  • CHA2DS2- VASc score: 5 
  • Creatinine clearance: 57 mL/min

FRANK IS LOOKING FOR CONTROL

 

Trying to eat better, joined a cooking class

Clinical characteristics

  • Age: 71, with atrial fibrillation
  • Current medications: ACE inhibitor, diuretic, oral antidiabetic agent, warfarin
  • Co-morbidities: Hypertension, heart failure, diabetes
  • CHA2DS2- VASc score: 3
  • Creatinine clearance: 50 mL/min
  • INR: Difficult to manage

JONATHAN REQUIRES A LOWER DOSE

 

Tries to eat better, not active.

Clinical characteristics

  • Age: 80, with atrial fibrillation
  • Current medications: Verapamil, oral antidiabetic agent
  • Co-morbidities: Diabetes, hypertension
  • CHA2DS2- VASc score: 4 
  • Creatinine clearance: 45 mL/min

Reference:

  1. PRADAXA Summary of Product Characteristics 2013. Boehringer Ingelheim.

How do I switch my patients to PRADAXA?

Switching is simple, learn how to switch your patients to PRADAXA

What about PRADAXA in real life?

Read about our real–world experience